JFDA approves Johnson & Johnson vaccine for emergency use

Monday, the Jordan Food and Drug Administration (JFDA) approved the COVID-19 Johnson & Johnson vaccine for emergency use. This makes Johnson & Johnson the fourth vaccine to get approved in the Kingdom after the Pfizer-BioNTech, Sinopharm and AstraZenenca vaccines.

Jordan began its national vaccination campaign, using the Pfizer-BioNTech and Sinopharm vaccines on Jan. 13. On Feb. 4, the Kingdom's health directorates began administering the second dose of the coronavirus vaccine in Jordan.